Back to results
CompletedPhase 2

NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease

NCT01600469

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung, Taiwan, Taiwan

View on ClinicalTrials.gov
NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease — TrialFind